SP-420

N/A

Report date: 2023/01/28 20:00:33
NME

Base Information

Drug NameSP-420
Drug Alias NameSP-420
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIron chelating agents
TargetsNot applicable
Therapy Area/IndicationsIron OverloadMyelodysplastic Syndromesbeta-Thalassemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesThailand +[6] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Florida
China Registration ClassN/A

Develop Information

Active CompaniesPharmacosmos A/S
Inactive CompaniesUT Health San AntonioSideris Pharmaceuticals IncAbfero Pharmaceuticals Inc
Active IndicationsMyelodysplastic Syndromesbeta-Thalassemia
Inactive IndicationsIron Overload

Other Information

ATC CodeN/A
Related LinksN/A